Non-infectious Uveitis Affecting the Posterior Segment of the Eye Clinical Trials in Bristol

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.